✦ LIBER ✦

The JAK-STAT Pathway: Signal Transduction Involved in Proliferation, Differentiation and Transformation

✍ Scribed by Weber-nordt, R. M. ;Mertelsmann, R. ;Finke, J.

Book ID: 121017722
Publisher: Informa plc
Year: 1998
Tongue: English
Weight: 864 KB
Volume: 28
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428199809058353

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stem Cell Factor, the JAK-STAT Pathway a

Stem Cell Factor, the JAK-STAT Pathway and Signal Transduction

✍ Linnekin, Diana ;Mou, Sherry ;Deberry, Candy S. ;Weiler, Sarah R. ;Keller, Jonat 📂 Article 📅 1997 🏛 Informa plc 🌐 English ⚖ 221 KB

P30 Urokinase activates the Jak/Stat sig

P30 Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Robustness of the signal transduction sy

Robustness of the signal transduction system of the mammalian JAK/STAT pathway and dimerization steps

✍ Emi Shudo; Jin Yang; Akihiko Yoshimura; Yoh Iwasa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Cyclin D-Cdk4 and Cyclin E-Cdk2 Regulate

Cyclin D-Cdk4 and Cyclin E-Cdk2 Regulate the JAK/STAT Signal Transduction Pathway in Drosophila

✍ Xiu Chen; Su-Wan Oh; Zhiyu Zheng; Hua-Wei Chen; Hyun-hee Shin; Steven X. Hou 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 507 KB

Role of the JAK/STAT Signal Transduction

Role of the JAK/STAT Signal Transduction Pathway in the Regulation of Gene Expression in CNS

✍ P. Dell'Albani; R. Santangelo; L. Torrisi; V. G. Nicoletti; A. M. Giuffrida Stel 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 369 KB

Defective Jak-STAT signal transduction p

Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-α

✍ Andreas Pansky; Pius Hildebrand; Elizaveta Fasler-Kan; Luisa Baselgia; Sylvia Ke 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 132 KB 👁 1 views

Advanced malignant melanoma is an aggressive malignancy with poor prognosis. Current therapeutic strategies have a modest success rate. The most promising treatment consists of a combination of chemotherapy with interferon-alpha, but complete response rates remain less than 15%. Interferon-alpha is